Physician profile
Christopher M Bates
NPI 1750791513
$10,654.16
in general payments reported to CMS, 2019-2025
23 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,649 · 2020: $1,994 · 2021: $1,875 · 2022: $1,439 · 2023: $1,152 · 2024: $2,010 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,700 · Food and Beverage: $1,518 · Travel and Lodging: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,700.00 |
| Food and Beverage | $1,518.29 |
| Travel and Lodging | $478.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,110.84 | 2020-2024 | |
| Microaire Surgical Instruments LLC | $1,700.00 | 2024 | |
| Acumed LLC | $1,683.89 | 2019-2025 | Innate Implant, Acumed, Inframe Implant |
| Acera Surgical, INC. | $1,085.09 | 2021-2025 | Restrata Wound Matrix |
| Arthrex, INC. | $1,029.66 | 2020 | |
| Sonex Health, INC. | $779.77 | 2023 | Sx-One Microknife |
| Tepha INC | $625.03 | 2019-2020 | |
| Stryker Corporation | $393.70 | 2020-2025 | Mako, Hoffmann |
| Exsomed Corporation | $228.06 | 2021 | |
| Trice Medical, INC. | $183.87 | 2023 | |
| Integra Lifesciences Corporation | $155.73 | 2022 | |
| Anika Therapeutics, INC. | $139.98 | 2021 | |
| Amgen INC. | $124.27 | 2024-2025 | Krystexxa |
| Next Science LLC | $103.01 | 2021 | |
| Motiva USA, LLC | $79.83 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $42.70 | 2023 | Krystexxa |
| Endo Pharmaceuticals INC. | $42.64 | 2021-2022 | |
| Hydrocision, INC. | $41.45 | 2022 | |
| Abbott Laboratories | $33.45 | 2021-2024 | Diamondback Coronary |
| Orthofix Medical, INC. | $26.25 | 2022-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $16.54 | 2023 | Quickanchor Ethibond, Gii, Microfix Quickanchor Ethibond |
| Dynasplint Systems INC. | $15.97 | 2020 | |
| Nevro Corp. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.